Teixobactin

N/A

Report date: 2022/08/24 20:00:31
NME

Base Information

Drug NameTeixobactin
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCell wall inhibitors
TargetsUpdating
Therapy Area/IndicationsStaphylococcal InfectionsTuberculosisGram-Positive Bacterial Infections +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of BonnNortheastern University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNortheastern UniversityUniversity Of BonnNovobiotic Pharmaceuticals LLC
Active IndicationsN/A
Inactive IndicationsStaphylococcal InfectionsTuberculosisGram-Positive Bacterial Infections +[4] 

Other Information

ATC CodeN/A
Related LinksN/A